SCHEMBL7550672

SCHEMBL7550672

c1ccc(-c2nc3cccnc3[nH]2)c(CNCCN2CCCCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 1/20 0.42
ALDH1A1 P00352 2/20 0.41
TSHR P16473 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ALOX15 P16050 1/20 0.41
HRH3 Q9Y5N1 4/20 0.41
ACHE P22303 2/20 0.39
APP P05067 2/20 0.39
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
TGFBR1 P36897 1/20 0.39
TGFBR2 P37173 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549624 0.86 ACHE (0.51) DPP7ALDH1A1TSHRL3MBTL1ACHE
SCHEMBL7546715 0.84 PDE5A (0.47) DPP7CARM1
SCHEMBL7553494 0.83 PDE5A (0.45) DPP7TSHRACHEAPPCYP1A2
SCHEMBL7552057 0.83 DPP7 (0.41) DPP7ALDH1A1TSHRL3MBTL1ACHE
SCHEMBL7549557 0.82 DPP7 (0.49) DPP7ALDH1A1TSHRL3MBTL1ALOX15
SCHEMBL7546612 0.80 CCR2 (0.51) DPP7ALDH1A1TSHRACHEAPP
SCHEMBL7554493 0.79 MAP4K4 (0.52) DPP7ALDH1A1TSHRL3MBTL1ALOX15
SCHEMBL7554529 0.78 HRH4 (0.44) DPP7TSHRHRH3ACHEAPP
SCHEMBL7553609 0.78 ACHE (0.52) DPP7ALDH1A1TSHRACHEAPP
SCHEMBL7550676 0.76 HRH3 (0.54) ALDH1A1HRH3ACHEKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020099054-A1 2-phenyl benzimidazole derivatives as MCP-1 antagonists WARNER-LAMBERT COMPANY (US) 2002-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099054-A1 2-phenyl benzimidazole derivatives as MCP-1 antagonists CCR1, CCR2, CCR8 DPP7 2503/4885ALDH1A1 2817/4885TSHR 499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.